Clascoterone cream for facial acne
Part of Skin clinical trials.
This trial tests a new cream called clascoterone for moderate to severe facial acne. It may help reduce pimples and blackheads with fewer side effects than some other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 12 years old or older.
- You have moderate to severe facial acne with at least 30 pimples and 30 blackheads or whiteheads.
- You have fewer than 2 large, painful bumps (nodules) on your face.
- You have not used any prescription acne creams, pills, or hormone treatments for acne in the past 4 weeks.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a cream called clascoterone (1%) for people ages 12 and up with moderate to severe facial acne. The cream is applied daily to help reduce pimples and clogged pores.
This trial tests a new acne cream called clascoterone compared to a standard cream, adapalene, for mild acne. It aims to see which one works better for clearing pimples.
This trial tests three different gel treatments for mild to moderate acne on the face. One gel contains clindamycin and retinoid, another adds dexamethasone, and the third uses a special stem-cell secretion. All are applied to the face for 8 weeks.
This trial tests a cream called KR230109 for mild to moderate facial acne. It aims to see if the cream is safe and works well. You may qualify if you are 18 to 40 and have at least 10 pimples and 20 blackheads or whiteheads on your face, but no deep cysts.
This trial studies whether putting antibiotic creams on mild-to-moderate facial acne reduces inflammation. It may help answer whether topical erythromycin or clindamycin can improve acne-related redness and swelling.
This trial tests if a new cleanser and cream combination can safely treat mild to moderate acne. It may help people who have not used other acne treatments recently.
Hear when a new Acne Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.